Pelago Bioscience and RG Discovery – New Opportunities in Drug Discovery

Pelago Bioscience invites you to an exclusive seminar and informal seminar and After Work, highlighting the company’s expanded capabilities following its acquisition of RG Discovery.

Pelago Bioscience specializes in cell biology and the CETSA® technology platform, while RG Discovery contributes extensive expertise in medicinal, computational and analytical chemistry. Together, the companies offer integrated drug discovery services—from Target Identification through to Candidate Drug.

During the seminar, the Pelago team will present cases illustrating these combined capabilities and discuss current R&D challenges and future needs in Early Discovery. The seminar will be followed by an informal After Work and an opportunity to connect with the team and other participants.

This is an invitation-only event. If the topic is relevant to your business and you would like to attend, please contact Sara, sara.gunneras@kiinnovation.se, with your name and any dietary requirements no later than 15:00 on 17 August. You are also welcome to share the invitation with relevant colleagues in your organization.

Hosts: Johan Evenäs, Robert Kronqvist and Michael Dabrowski, Pelago Bioscience & RG Discovery.